Diana Burns
Nurse Practitioner · Portsmouth, OHNPI 1598197162
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 37.7% of the total. 2025 is the largest year on record at $941, 2.8 times the $331 reported in 2021. Among nurse practitioner clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$947
- Alkermes, Inc.$236
- Axsome Therapeutics, Inc.$202
- Gilead$176
- Otsuka America Pharmaceutical, Inc.$135
- Teva Pharmaceuticals USA, Inc.$121
- plus $692 from 15 others
What the payments were for
- Food & beverage$2,510100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $947 |
| Alkermes, Inc. | 11 | $236 |
| Axsome Therapeutics, Inc. | 6 | $202 |
| Gilead | 11 | $176 |
| Otsuka America Pharmaceutical, Inc. | 8 | $135 |
| Teva Pharmaceuticals USA, Inc. | 7 | $121 |
| Novo Nordisk | 1 | $113 |
| Vanda Pharmaceuticals Inc. | 4 | $100 |
| Neurocrine Biosciences, Inc. | 4 | $81 |
| Braeburn Inc. | 4 | $57 |
| E.r. Squibb & Sons, L.L.C. | 2 | $56 |
| Indivior Inc. | 3 | $56 |
| Johnson & Johnson | 2 | $46 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 2 | $26 |
| Organon | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Orexo US, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,510 in reported general payments places this provider in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrixadiBuprenorphine | 11 | $16,861 |
| Oxcarbazepine | 38 | $1,277 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $926 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $561 |
| Ibuprofen | 26 | $202 |
| Quetiapine Fumarate | 18 | $181 |
| Propranolol Hcl | 15 | $172 |
| Fluoxetine Hcl | 13 | $140 |
| Amitriptyline Hcl | 22 | $122 |
| Lisinopril | 40 | $101 |
| Naproxen | 16 | $101 |
| Buspirone Hcl | 11 | $89 |
| Clonidine Hcl | 30 | $89 |
| Acyclovir | 12 | $55 |
| Pantoprazole Sodium | 16 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braeburn Inc.Brixadi | $57 | $16,86111 claims |
| Teva Pharmaceuticals USA, Inc.Acyclovir | $121 | $5512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,700 nurse practitioner providers in Ohio.
Other nurse practitioner in Portsmouth
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.